GT Biopharma, Inc. , a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform.
Gt Biopharma stock last closed at $2.17, down 4.41% from the previous day, and has decreased 42.59% in one year. It has overperformed other stocks in the Biotechnology industry by 0.35 percentage points. Gt Biopharma stock is currently +26.16% from its 52-week low of $1.72, and -79.64% from its 52-week high of $10.66.
As of Apr 21, 2025, there are 2.23M GTBP shares outstanding. The market capitalization of GTBP is $4.85M. In the last 24 hours, 4953 GTBP shares were traded.
You need a brokerage account to access the NASDAQ market and buy GTBP shares.
Based on our analysis, eToro is the best brokerage. Here's why:
Get $10 towards your stock purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've picked the right brokerage, it's time to fill out some personal details so you are able to invest in GTBP today.
Now that you've created your account on the best stock trading app, your next step is to transfer the money for your investment:
Watch the tutorial below for more details depositing funds into your new brokerage account.
Once you have figured out the best place to buy Gt Biopharma stock, it's critical to research their stock prior to investing, so you actually understand the risk and opportunity.
WallStreetZen was built to help average investors perform more accurate fundamental analysis quickly.
You can view all of the due diligence checks on GTBP's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge GTBP's true value.
You can do additional valuation research on GTBP's stock here.
Out of 1 sell side analysts who give ratings on GTBP, the consensus analyst rating on GTBP is a Strong Buy
It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they financial advice.
You can dive deeper into what analysts are projecting on the Gt Biopharma stock forecast page.
In the last year, executives and large shareholders at GTBP have not bought or sold any shares.
Get more info about who owns GTBP stock here.
No, Gt Biopharma doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
There are two main types of orders:
Hit the Open Trade button and your broker will place your order.
If you want additional help with investing in stocks on eToro, watch the how to video below:
Now that you own some shares in GTBP, you'll want to stay up-to-date on your new investment.
Put GTBP on a watchlist to get notified of the latest news about your GTBP stock.
To summarize, here are the 6 steps you need to take to buy Gt Biopharma stock right now:
If you require a brokerage account, eToro is our favorite option.
Get Started with eToro TodayIf you want to get updates on your investment in Gt Biopharma, get started below.